» Articles » PMID: 19224636

Pattern and Diversity of Cytokine Production Differentiates Between Mycobacterium Tuberculosis Infection and Disease

Overview
Journal Eur J Immunol
Date 2009 Feb 19
PMID 19224636
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

Tuberculosis (TB) remains a global health problem. The solution involves development of an effective vaccine, but has been limited by incomplete understanding of what constitutes protective immunity during natural infection with Mycobacterium tuberculosis. In this study, M. tuberculosis-specific responses following an overnight whole-blood assay were assessed by intracellular cytokine staining and luminex, and compared between TB cases and exposed household contacts. TB cases had significantly higher levels of IFN-gamma(+)TNF-alpha(+)IL-2(+)CD4(+)T cells compared with contacts. TB cases also had a significantly higher proportion of cells single-positive for TNF-alpha, but lower proportion of cells producing IL-2 alone and these differences were seen for both CD4(+)and CD8(+) T cells. Cytokine profiles from culture supernatants were significantly biased toward a Th1 phenotype (IFN-gamma and IL-12(p40)) together with a complete abrogation of IL-17 secretion in TB cases. Our data indicate that despite a robust response to TB antigens in active TB disease, changes in the pattern of cytokine production between TB infection and disease clearly contribute to disease progression.

Citing Articles

Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection.

Panda S, Morgan J, Cheng C, Saito M, Gilman R, Ciobanu N Nat Commun. 2024; 15(1):765.

PMID: 38278794 PMC: 10817963. DOI: 10.1038/s41467-024-45058-9.


Shift in Tissue-Specific Immune Niches and CD137 Expression in Tuberculoma of Pembrolizumab-Treated Nasopharyngeal Carcinoma Patients.

Kam N, Lo A, Hung D, Ko H, Wu K, Kwong D Cancers (Basel). 2024; 16(2).

PMID: 38254759 PMC: 10813936. DOI: 10.3390/cancers16020268.


Immunogenicity of PE18, PE31, and PPE26 proteins from in humans and mice.

Garcia-Bengoa M, Vergara E, Tran A, Bossi L, Cooper A, Pearl J Front Immunol. 2023; 14:1307429.

PMID: 38124744 PMC: 10730732. DOI: 10.3389/fimmu.2023.1307429.


Bridging the gaps to overcome major hurdles in the development of next-generation tuberculosis vaccines.

Kim H, Choi H, Shin S Front Immunol. 2023; 14:1193058.

PMID: 37638056 PMC: 10451085. DOI: 10.3389/fimmu.2023.1193058.


LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA in Chinese healthy male subjects.

Cao G, Wang J, He J, Hu Y, Yang H, Que L Front Pharmacol. 2023; 14:1111893.

PMID: 37081963 PMC: 10110837. DOI: 10.3389/fphar.2023.1111893.